text_1: Pioglitazone use is significantly associated with an increased risk of prostate cancer.
text_2: A bladder cancer cohort followed 193,099 persons aged 40 years or older in 1997-2002 until December 2012; 464 case patients and 464 matched controls were surveyed about additional confounders.